{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T04:45:54Z","timestamp":1782535554846,"version":"3.54.5"},"reference-count":34,"publisher":"Medical Association of Nippon Medical School","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nippon Med Sch"],"published-print":{"date-parts":[[2026,6,20]]},"DOI":"10.1272\/jnms.jnms.2026_93-309","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T22:08:41Z","timestamp":1782425321000},"page":"244-251","source":"Crossref","is-referenced-by-count":0,"title":["Interferon Regulatory Factor Family Transcription Factor Expression in the Dorsal Root Ganglion of a Rat Model of Neuropathic Pain"],"prefix":"10.1272","volume":"93","author":[{"given":"Yuji","family":"Watanabe","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoyo","family":"Maruyama","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Nippon Medical School"},{"name":"Division of Laboratory Animal Science, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miki","family":"Yokoyama","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Nippon Medical School"},{"name":"Department of Dental Anesthesiology, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Arakawa","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Sakai","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"21","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Pinho-Ribeiro FA, Verri WA, Chiu IM. Nociceptor sensory neuron-immune interactions in pain and inflammation. Trends Immunol. 2017 Jan;38 (1):5\u201319.","DOI":"10.1016\/j.it.2016.10.001"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Gazerani P. Satellite glial cells in pain research: a targeted viewpoint of potential and future directions. Front Pain Res (Lausanne). 2021 Mar 10;2:646068.","DOI":"10.3389\/fpain.2021.646068"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Zhang WJ, Liu SC, Ming LG, et al. Potential role of Schwann cells in neuropathic pain. Eur J Pharmacol. 2023 Oct 5;956:175955.","DOI":"10.1016\/j.ejphar.2023.175955"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Malcangio M, Sideris-Lampretsas G. How microglia contribute to the induction and maintenance of neuropathic pain. Nat Rev Neurosci. 2025 May;26:263\u201375.","DOI":"10.1038\/s41583-025-00914-5"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Zhang Z, Niu Z, Dong S. Spinal glia-driven neuroinflammation as a therapeutic target for neuropathic pain: rational development of novel analgesics. Neurosci Biobehav Rev. 2025 Dec;179:106404.","DOI":"10.1016\/j.neubiorev.2025.106404"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Garcia-Dominguez M. Injury-driven structural and molecular modifications in nociceptors. Biology (Basel). 2025 Jun 29;14 (7):788.","DOI":"10.3390\/biology14070788"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Ito T, Sakai A, Maruyama M, et al. Dorsal Root Ganglia Homeobox downregulation in primary sensory neurons contributes to neuropathic pain in rats. Mol Pain. 2020 Jan;16:1\u201311.","DOI":"10.1177\/1744806920904462"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Li R, Wang LG, Wang Q, Li ZH, Ma YL, Guo QD. Silencing of IRF3 alleviates chronic neuropathic pain following chronic constriction injury. Biomed Pharmacother. 2017 Apr;88:403\u20138.","DOI":"10.1016\/j.biopha.2017.01.085"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Wang L, Zhu Y, Zhang N, et al. The multiple roles of interferon regulatory factor family in health and disease. Signal Transduct Target Ther. 2024 Oct 9;9 (1):282.","DOI":"10.1038\/s41392-024-01980-4"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Masuda T, Iwamoto S, Mikuriya S, et al. Transcription factor IRF1 is responsible for IRF8-mediated IL-1\u03b2 expression in reactive microglia. J Pharmacol Sci. 2015 Aug;128 (4):216\u201320.","DOI":"10.1016\/j.jphs.2015.08.002"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Zhang Z, Zhang T, Zhang Y, Liang Y. CCL17 blockade by CCL17mAb\/GSK-J4 ameliorates hyperalgesia in a rat model of postoperative pain. Biol Pharm Bull. 2023 Apr 1;46 (4):533\u201341.","DOI":"10.1248\/bpb.b22-00463"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Masuda T, Iwamoto S, Yoshinaga R, et al. Transcription factor IRF5 drives P2X4R<sup>+<\/sup>-reactive microglia gating neuropathic pain. Nat Commun. 2014 May 13;5:3771.","DOI":"10.1038\/ncomms4771"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Terashima T, Ogawa N, Nakae Y, et al. Gene therapy for neuropathic pain through siRNA-IRF5 gene delivery with homing peptides to microglia. Mol Ther Nucleic Acids. 2018 Jun 1;11:203\u201315.","DOI":"10.1016\/j.omtn.2018.02.007"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Wu CC, Chang CY, Tzeng CY, et al. Preventive intrathecal injection of bupivacaine alleviated microglia activation and neuropathic pain in a rat model of chronic constriction injury. Int J Mol Sci. 2022 Jun 28;23 (13):7197.","DOI":"10.3390\/ijms23137197"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Masuda T, Tsuda M, Yoshinaga R, et al. IRF8 is a critical transcription factor for transforming microglia into a reactive phenotype. Cell Rep. 2012 Apr 19;1 (4):334\u201340.","DOI":"10.1016\/j.celrep.2012.02.014"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Jiang S, Li Z, Huang SJ, Zou W, Luo JG. IRF7 overexpression alleviates CFA-induced inflammatory pain by inhibiting nuclear factor-\u03baB activation and pro-inflammatory cytokines expression in rats. Brain Behav Immun. 2024 Aug;120:10\u201320.","DOI":"10.1016\/j.bbi.2024.05.021"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Rahman MM, Hwang SM, Go EJ, Kim YH, Park CK. Irisin alleviates CFA-induced inflammatory pain by modulating macrophage polarization and spinal glial cell activation. Biomed Pharmacother. 2024 Sep;178:117157.","DOI":"10.1016\/j.biopha.2024.117157"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 1983 Jun;16 (2):109\u201310.","DOI":"10.1016\/0304-3959(83)90201-4"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19. Kim SH, Chung JM. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain. 1992 Sep;50 (3):355\u201363.","DOI":"10.1016\/0304-3959(92)90041-9"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods. 2012 Jul;9 (7):671\u20135.","DOI":"10.1038\/nmeth.2089"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Yaksh TL, Dirksen R, Harty GJ. Antinociceptive effects of intrathecally injected cholinomimetic drugs in the rat and cat. Eur J Pharmacol. 1985 Oct 29;117 (1):81\u20138.","DOI":"10.1016\/0014-2999(85)90474-1"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Jia X, Ju J, Li Z, Peng X, Wang J, Gao F. Inhibition of spinal BRD4 alleviates pyroptosis and M1 microglia polarization via STING-IRF3 pathway in morphine-tolerant rats. Eur J Pharmacol. 2024 Apr 15;969:176428.","DOI":"10.1016\/j.ejphar.2024.176428"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Gao Y, Mei C, Chen P, Chen X. The contribution of neuro-immune crosstalk to pain in the peripheral nervous system and the spinal cord. Int Immunopharmacol. 2022 Jun;107:108700.","DOI":"10.1016\/j.intimp.2022.108700"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Fiore NT, Debs SR, Hayes JP, Duffy SS, Moalem-Taylor G. Pain-resolving immune mechanisms in neuropathic pain. Nat Rev Neurol. 2023 Apr;19:199\u2013220.","DOI":"10.1038\/s41582-023-00777-3"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Moorman HR, Reategui Y, Poschel DB, Liu K. IRF8: mechanism of action and health implications. Cells. 2022 Aug 24;11 (17):2630.","DOI":"10.3390\/cells11172630"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Wang Y, Shen Y, Liang J, et al. Neurons upregulate PD-L1 via IFN\/STAT1\/IRF1 to alleviate damage by CD8<sup>+<\/sup> T cells in cerebral malaria. J Neuroinflammation. 2024 May 7;21:119.","DOI":"10.1186\/s12974-024-03114-7"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Zhao J, Chen C, Xiao JR, et al. An up-regulation of IRF-1 after a spinal cord injury: implications for neuronal apoptosis. J Mol Neurosci. 2015;57:595\u2013604.","DOI":"10.1007\/s12031-015-0642-2"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Guo S, Li ZZ, Jiang DS, et al. IRF4 is a novel mediator for neuronal survival in ischaemic stroke. Cell Death Differ. 2014 Jun;21:888\u2013903.","DOI":"10.1038\/cdd.2014.9"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Fang H, Li HF, Yan JY, Yang M, Zhang JP. Dexmedetomidine-up-regulated microRNA-381 exerts anti-inflammatory effects in rats with cerebral ischaemic injury via the transcriptional factor IRF4. J Cell Mol Med. 2021 Feb;25 (4):2098\u2013109.","DOI":"10.1111\/jcmm.16153"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Qing F, Liu Z. Interferon regulatory factor 7 in inflammation, cancer and infection. Front Immunol. 2023 May 12;14:1190841.","DOI":"10.3389\/fimmu.2023.1190841"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Lawson SN, Fang X, Djouhri L. Nociceptor subtypes and their incidence in rat lumbar dorsal root ganglia (DRGs): focussing on C-polymodal nociceptors, A\u03b2-nociceptors, moderate pressure receptors and their receptive field depths. Curr Opin Physiol. 2019 Oct;11:125\u201346.","DOI":"10.1016\/j.cophys.2019.10.005"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Ebbinghaus M, Natura G, Segond von Banchet G, et al. Interleukin-17A is involved in mechanical hyperalgesia but not in the severity of murine antigen-induced arthritis. Sci Rep. 2017 Sep 4;7:10334.","DOI":"10.1038\/s41598-017-10509-5"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Almuttaqi H, Udalova IA. Advances and challenges in targeting IRF5, a key regulator of inflammation. FEBS J. 2019 May;286 (9):1624\u201337.","DOI":"10.1111\/febs.14654"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Mamun AA, Liu F. Role of IRF4-mediated inflammation: implication in neurodegenerative diseases. Neurol Neurother Open Access J. 2017;2 (1):107.","DOI":"10.23880\/NNOAJ-16000107"}],"container-title":["Journal of Nippon Medical School"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnms\/93\/3\/93_JNMS.2026_93-309\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T04:04:46Z","timestamp":1782533086000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnms\/93\/3\/93_JNMS.2026_93-309\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,20]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1272\/jnms.jnms.2026_93-309","relation":{},"ISSN":["1345-4676","1347-3409"],"issn-type":[{"value":"1345-4676","type":"print"},{"value":"1347-3409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,20]]},"article-number":"JNMS.2026_93-309"}}